Hultgren, Nan W. http://orcid.org/0000-0002-4116-391X
Fang, Jennifer S. http://orcid.org/0000-0001-5703-2239
Ziegler, Mary E.
Ramirez, Ricardo N. http://orcid.org/0000-0002-1259-5406
Phan, Duc T. T.
Hatch, Michaela M. S.
Welch-Reardon, Katrina M.
Paniagua, Antonio E. http://orcid.org/0000-0002-2526-8412
Kim, Lin S.
Shon, Nathan N. http://orcid.org/0000-0001-5282-1773
Williams, David S.
Mortazavi, Ali http://orcid.org/0000-0002-4259-6362
Hughes, Christopher C. W. http://orcid.org/0000-0002-3223-830X
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32CA009054)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (UM1HG009443)
Article History
Received: 14 August 2018
Accepted: 1 September 2020
First Online: 26 October 2020
Competing interests
: All authors except C.C.W.H. and D.T.T.P. declare no competing interests. Principal Investigator C.C.W.H. has an equity interest in Aracari Biosciences, Inc, which is commercializing the microfluidic device used in this paper. D.T.T.P. serves as a scientist at Aracari Biosciences and receives stock and financial compensation from Aracari Biosciences. The terms of this arrangement have been reviewed and approved by the University of California, Irvine in accordance with its conflict of interest policies.